Global Ophthalmic Viscoelastic Device (OVD) Market Outlook 2018-2023

It is estimated that the Global Ophthalmic Viscoelastic Device (OVD) Market would develop at a substantial CAGR in the forthcoming years. Ophthalmic Viscoelastic Devices (OVDs) are the therapeutic instruments utilized in the surgical treatment of cataract with the intention of making and upholding the space in the front cavity of the eye for phacoemulsification and insertion of an Intraocular Lens (IOL). There are a number of categories of the ophthalmic viscoelastic devices for example cohesive ophthalmic viscoelastic device and dispersive ophthalmic viscoelastic device. Maximum of the ophthalmic viscoelastic devices (OVDs) comprise hydroxypropyl methylcellulose (HPMC) or sodium hyaluronate (NaHA).

Growth in the incidences of eye sicknesses and increase in the sum of glaucoma and cataract surgical treatment are motivating the development of the market for ophthalmic viscoelastic devices (OVDs). The promising strategies of compensation for the surgical treatment done consuming ophthalmic viscoelastic devices (OVDs) and planned methodology of the manufacturing companies benefiting them bear the development and extension in the market.

On the other hand, absence of alertness between the healthcare groups, deprived substructure of healthcare substructure and the obtainability of alternative treatments may possibly hamper the development of the market of ophthalmic viscoelastic devices (OVDs), above the forecast period.

By type of Product the Ophthalmic Viscoelastic Device (OVD) market is divided into Dispersive OVDs, Cohesive OVDs. By type of Application the market is divided in to Vitreoretinal Surgery, Glaucoma Surgery, Corneal Transplantation, and Cataract Surgery. By End User the market is divided into Research Organizations & Educational segment, Ophthalmic Health center & Phaco Centers and Hospitals. 

By geography the market is divided into North America (U.S.A, Canada, Mexico), Europe (France, Germany, U.K., Russia and others), Asia Pacific (India, Japan, China, Australia, and others), Middle East & Africa (Saudi Arabia, South Africa and others), and South America (Argentina, Brazil, and others)

The development of the North American ophthalmic viscoelastic devices market is motivated by the growth in eye illnesses. The increasing elderly populace and greater implementation of the latest technology are likely to motivate the development of the market in the area. The European market is tracking North America. It stands on the subsequent place. The increasing alertness regarding the unconventional treatments between the patient population and greater per head earnings of developing marketplaces in the area are motivating development of the market. The market in the Asia Pacific is projected to be speedily developing above the forecast period.

The group effort, unifications & acquisitions among companies are assisting to motivate the R&D actions that are likely to generate the development of the Ophthalmic Viscoelastic Device (OVD) Market. The company named “Rayner”, which is original maker of intraocular lenses for cataract surgical treatment, has picked up the business of ophthalmic cataract surgery of a Geneva-based Swiss company named Aptissen SA , during the past year. 

Some of the important companies operating in the field of Ophthalmic Viscoelastic Device (OVD) at the international level are Shanghai Haohai Bio Technology Company Limited, Carl Zeiss Meditec AG, Johnson & Johnson Surgical Vision, Inc. Additional notable companies operating in the field are Life core Biomedical LLC, Rayner Company, Bausch & Lomb, Bohus BioTech AB, Carl Zeiss AG, Alcon Laboratories Inc.

The 'Global Ophthalmic Viscoelastic Device (OVD) Market Outlook 2018-2023' offers detailed coverage of ophthalmic viscoelastic device industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading ophthalmic viscoelastic device producers to provide exhaustive coverage of the market for ophthalmic viscoelastic device. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.

The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global ophthalmic viscoelastic device market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Key Regions
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America

Key Vendors
- Carl Zeiss Meditec AG
- Johnson & Johnson Surgical Vision, Inc.
- Shanghai Haohai Bio Technology Company Limited.
- request free sample to get a complete list of companies

Key Questions Answered in This Report
- Analysis of the ophthalmic viscoelastic device market including revenues, future growth, market outlook
- Historical data and forecast
- Regional analysis including growth estimates
- Analyzes the end user markets including growth estimates.
- Profiles on ophthalmic viscoelastic device including products, sales/revenues, and market position
- Market structure, market drivers and restraints.